Diagnostic role of circulating MiR-21 in colorectal cancer: a update meta-analysis

References

• Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2009. CA Cancer J Clin. 2009;59(4):225–249.
   PubMed Web of Science ®Google Scholar
• Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012. CA Cancer J Clin. 2012;62(1):10–29.
   PubMed Web of Science ®Google Scholar
• Luo X, Burwinkel B, Tao S, et al. MicroRNA signatures: novel biomarker for colorectal cancer? Cancer Epidemiol Biomarkers Prev. 2011;20(7):1272–1286.
   PubMed Web of Science ®Google Scholar
• Levin B, Lieberman DA, Andrews KS, American College of Radiology Colon Cancer Committee, et al. Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. CA Cancer J Clin. 2008;58(3):130–160.
   PubMed Web of Science ®Google Scholar
• Bushati N, Cohen SM. MicroRNA functions. Annu Rev Cell Dev Biol. 2007;23:175–205.
   PubMed Web of Science ®Google Scholar
• Mishra PJ. MicroRNAs as promising biomarkers in cancer diagnostics. Biomark Res. 2014;2(19):19.
   PubMedGoogle Scholar
• Sempere LF. Recent advances in miRNA-based diagnostic applications. Expert Rev Mol Diagn. 2012;12(6):557–559.
   PubMedGoogle Scholar
• Meng F, Henson R, Wehbe-Janek H, et al. MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer. Gastroenterology. 2007;133(2):647–658.
   PubMed Web of Science ®Google Scholar
• Zhu S, Si ML, Wu H, et al. MicroRNA-21 targets the tumor suppressor gene tropomyosin 1 (TPM1). J Biol Chem. 2007;282(19):14328–14336.
   PubMed Web of Science ®Google Scholar
• Asangani IA, Rasheed SA, Nikolova DA, et al. MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer. Oncogene. 2008;27(15):2128–2136.
   PubMed Web of Science ®Google Scholar
• Schetter AJ, Leung SY, Sohn JJ, et al. MicroRNA expression profifiles associated with prognosis and therapeutic outcome in colon adenocarcinoma. JAMA. 2008;299(4):425–436.
   PubMed Web of Science ®Google Scholar
• Kulda V, Pesta M, Topolcan O, et al. Relevance of miR-21 and miR-143 expression in tissue samples of colorectal carcinoma and its liver metastases. Cancer Genet Cytogenet. 2010;200(2):154–160.
   PubMedGoogle Scholar
• Shibuya H, Iinuma H, Shimada R, et al. Clinicopathological and prognostic value of microRNA-21 and microRNA-155 in colorectal cancer. Oncology. 2010;79(3-4):313–320.
   PubMed Web of Science ®Google Scholar
• Nielsen BS, Jørgensen S, Fog JU, et al. High levels of microRNA-21 in the stroma of colorectal cancers predict short disease-free survival in stage II colon cancer patients. Clin Exp Metastasis. 2011;28(1):27–38.
   PubMed Web of Science ®Google Scholar
• Xu F, Xu L, Wang M, et al. The accuracy of circulating microRNA-21 in the diagnosis of colorectal cancer: a systematic review and meta-analysis. Colorectal Dis. 2015;17(5):O100–107.
   PubMed Web of Science ®Google Scholar
• Yu W, Wang Z, Shen L, et al. Circulating microRNA-21 as a potential diagnostic marker for colorectal cancer: a meta-analysis. Mol Clin Oncol. 2016;4(2):237–244.
   PubMed Web of Science ®Google Scholar
• Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. PLoS Med. 2009;6(7):e1000100.
   PubMed Web of Science ®Google Scholar
• Sazanov AA, Kiselyova EV, Zakharenko AA, et al. Plasma and saliva miR-21 expression in colorectal cancer patients. J Appl Genetics. 2017;58(2):231–237.
   PubMed Web of Science ®Google Scholar
• Basati G, Emami Razavi A, Abdi S, et al. Elevated level of microRNA-21 in the serum of patients with colorectal cancer. Med Oncol. 2014;31(10):205.
   PubMed Web of Science ®Google Scholar
• Liu G, Zhou Z, Chen R, et al. Serum miR-21 and miR-92a as biomarkers in the diagnosis and prognosis of colorectal cancer. Tumor Biol. 2013;34(4):2175–2181.
   PubMedGoogle Scholar
• Fouad H, Sabry D, Morsi H, et al. XRCC1 gene polymorphisms and miR-21 expression in patients with colorectal carcinoma. Eurasian J Med. 2017;49(2):132–136.
   PubMed Web of Science ®Google Scholar
• Sarlinova M, Halasa M, Mistuna D, et al. miR 21, miR 221 and miR 150 are deregulated in peripheral blood of patients with colorectal cancer. AR. 2016;36(10):5449–5454.
   Web of Science ®Google Scholar
• Bastaminejad S, Taherikalani M, Ghanbari R, et al. Investigation of microRNA-21 expression levels in serum and stool as a potential non-invasive biomarker for diagnosis of colorectal cancer. IBJ. 2017;21(2):106–113.
   Google Scholar
• Jin X-H, Lu S, Wang A-F. Expression and clinical significance of miR-4516 and miR-21-5p in serum of patients with colorectal cancer. BMC Cancer . 2020;20(1):241.
   PubMed Web of Science ®Google Scholar
• Toiyama Y, Takahashi M, Hur K, et al. Serum miR-21 as a diagnostic and prognostic biomarker in colorectal cancer. J Natl Cancer Inst. 2013;105(12):849–859.
   PubMedGoogle Scholar
• Sabry D, El-Deek SEM, Maher M, et al. Role of miRNA-210, miRNA-21 and miRNA-126 as diagnostic biomarkers in colorectal carcinoma: impact of HIF-1α-VEGF signaling pathway. Mol Cell Biochem. 2019;454(1-2):177–189.
   PubMed Web of Science ®Google Scholar
• Hua H, Hao H, Han C, et al. Value of combined detection of serum miR-21 and miR-92 in diagnosis and recurrence of colorectal cancer. Shandong Med. 2018; 58(8):81–83.
   Google Scholar
• Chen J, Wang C, Yuan G, et al. Application of combined detection of miR-21, miR-210 and miR－92a in diagnosis of colorectal cancer. Chin J Health Lab Tec. 2019;2(10):1194–1198.
   Google Scholar
• Song Y, He M, Shao D, et al. Study on the expression of serum miR-21 in patients with benign and malignant colorectal diseases. J Med Res. 2013;42(9):124–128.
   Google Scholar
• Wang B, Zhang Q. The expression and clinical significance of circulating microRNA-21 in serum of five solid tumors. J Cancer Res Clin Oncol. 2012;138(10):1659–1666.
   PubMed Web of Science ®Google Scholar
• Ogata-Kawata H, Izumiya M, Kurioka D, et al. Circulating exosomal microRNAs as biomarkers of colon cancer. PloS ONE. 2014;9(4):e92921.
   PubMed Web of Science ®Google Scholar
• Zhang H, Li P, Ju H, et al. Diagnostic and prognostic value of microRNA-21 in colorectal cancer: an original study and individual participant data meta-analysis. Cancer Epidemiol Biomarkers Prev. 2014;23(12):2783–2792.
   PubMed Web of Science ®Google Scholar
• Du M, Liu S, Gu D, et al. Clinical potential role of circulating microRNAs in early diagnosis of colorectal cancer patients. Carcinogenesis. 2014;35(12):2723–2730.
   PubMed Web of Science ®Google Scholar
• Luo X, Stock C, Burwinkel B, et al. Burwinkel Band Brenner H: identification and evaluation of plasma microRNAs for early detection of colorectal cancer. PloS One. 2013;8(5):e62880.
   PubMed Web of Science ®Google Scholar
• Kanaan Z, Rai SN, Eichenberger MR, et al. Plasma miR-21: a potential diagnostic marker of colorectal cancer. Ann Surg. 2012;256(3):544–551.
   PubMed Web of Science ®Google Scholar